Why the study?
The appropriate use of dual antiplatelet therapy in elderly patients with ACS is debated due to challenges balancing ischemic risk reduction and hemorrhagic complications, with current underutilization despite guidelines.
This consensus document provides guidance on balancing ischemic and bleeding risks when prescribing DAPT to elderly patients with ACS.
No takes yet. Share an insight, caveat, or question.
Tarantini et al. (2018) conducted a review in Acute coronary syndrome (ACS). Dual antiplatelet therapy (DAPT) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: